Last updated on September 2018

Dose Finding Study of MCI-186 in Acute Ischemic Stroke

Brief description of study

To investigate the efficacy and safety of MCI-186 (bolus followed by continuous infusion) in acute ischemic stroke patients through a double-blind, parallel-group comparison with the existing MCI-186 dosing regimen (administration twice daily for 14 days) as the control.

Clinical Study Identifier: NCT03346538

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Information Desk, to ...

Investigational site 13
Aichi, Japan